Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.
about
Patient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMeTreatment of narcolepsy and other hypersomnias of central originPractice parameters for the treatment of narcolepsy and other hypersomnias of central originFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansModafinil enhances thalamocortical activity by increasing neuronal electrotonic couplingEfficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysisDaytime sleepiness in elderly Parkinson's disease patients and treatment with the psychostimulant modafinil: A preliminary study.Modafinil and memory: effects of modafinil on Morris water maze learning and Pavlovian fear conditioning.Modafinil-induced conditioned place preference via dopaminergic system in mice.Modafinil: Parkinson disease-related somnolenceMonoamine reuptake inhibitors in Parkinson's disease.Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.Modafinil in sports: ethical considerationsModafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.Dopamine agonists in Parkinson's disease.The ethics of elective psychopharmacologyDifferential effects of wake promoting drug modafinil in aversive learning paradigms.Modafinil: new indications for wake promotion.Effects of Modafinil on Behavioral Learning and Hippocampal Synaptic Transmission in Rats.Emerging drugs for Parkinson's disease.Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.Update on the use of pramipexole in the treatment of Parkinson's disease.Evidence-based recommendations for the assessment and management of sleep disorders in older personsAgitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.Cognitive impairment and dementia in Parkinson's disease: practical issues and management.Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials.Evaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.2-(Methyl-sulfin-yl)benzamideModafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study.Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers.Effective oxidation of sulfides to sulfoxides with hydrogen peroxide under transition-metal-free conditions.Modafinil attenuates inflammation via inhibiting Akt/NF-κB pathway in apoE-deficient mouse model of atherosclerosis.Dramatic Influence of Ionic Liquid and Ultrasound Irradiation on the Electrophilic Sulfinylation of Aromatic Compounds by Sulfinic Esters.
P2860
Q24595345-0FBC71CF-042E-4D80-9E55-12F3BDAA3465Q24648883-803A9AA4-F6F4-4620-98B5-CBB5E1B3DC4CQ24648903-C33328A7-3BA5-4766-9E05-687AE22C8125Q24654140-D496FAA7-6C66-44B5-8C94-9C7C7FE7C73CQ24669824-35A488A9-B9E5-4F73-B26E-B37CA97DB6F9Q28535752-75DD3807-1160-4799-907C-847DF24D3D27Q33787218-B0C3F424-AFF0-4076-9917-2DD43F9D29B7Q33908171-E6C47AF5-9E7F-4F0A-BEFB-241AB7CE1F13Q34154970-B7185563-3AE5-4945-8D17-6BF4041BF6C5Q34612982-50F014F0-E24B-4B73-9747-60B19CAF40B2Q35165280-17AFFA5D-2C5D-4118-ACDD-40B0278572E6Q35211225-565A9C98-B39C-4E5A-BECC-F5BEB0E9E2F8Q35332987-AFF4CEE0-7262-483A-8073-6462A4D5E2E0Q35485478-62C9051D-FEE0-425C-AC77-418630373940Q35570952-206CFC5A-DD80-463A-B9EF-11AAC3B2FAE1Q35886546-CAC783D4-F42E-4FAB-88E2-29B0C52ECA80Q35969858-1F9D1DAF-776F-445B-A982-A1C040813A14Q36040715-24EA28C7-48A3-4720-BBF0-E81626366956Q36438243-EB31485C-773F-4852-B363-785F336241E6Q36580572-30234DD5-F8F6-4644-8A04-2DCA89BC4487Q36632760-E07EC5B9-08C9-4DF1-980F-4842D75117E7Q36842189-3ADAF55C-EBC9-4A37-BB1C-3357AD04CFC1Q37356250-C90F77F4-3A0B-41EF-AF5E-82875DC886FFQ37734694-779794BC-F40A-44D1-A76A-4F0A6A16DDDDQ38206499-C63A7F55-F2EC-4F7E-B03C-009ACBCEE0BEQ38834412-CF519AFD-DCE7-42BE-9795-CA0868AE8334Q39000540-47CC9555-DC00-4000-B5DD-3613C06CE00DQ41516351-7671C3EA-754C-4BC6-A09F-51C54B6740A0Q45286756-E7537EDB-BB54-4652-A313-B742FE1CE8E7Q46792317-5C6D2958-9D15-4412-B590-3D11585B2051Q46886108-106F1AD8-91CD-446E-B1BD-77378A0A01D1Q47286486-55698C66-D657-48DC-8809-E021E1F9101BQ48204396-C19877DB-3A3C-4C7E-AC38-B97E19F80D49Q50190327-21BF0286-DAE9-413F-AC55-6B7EC4F9D5B1
P2860
Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of excessive daytime ...... nson's disease with modafinil.
@ast
Treatment of excessive daytime ...... nson's disease with modafinil.
@en
Treatment of excessive daytime ...... nson's disease with modafinil.
@nl
type
label
Treatment of excessive daytime ...... nson's disease with modafinil.
@ast
Treatment of excessive daytime ...... nson's disease with modafinil.
@en
Treatment of excessive daytime ...... nson's disease with modafinil.
@nl
prefLabel
Treatment of excessive daytime ...... nson's disease with modafinil.
@ast
Treatment of excessive daytime ...... nson's disease with modafinil.
@en
Treatment of excessive daytime ...... nson's disease with modafinil.
@nl
P921
P1476
Treatment of excessive daytime ...... nson's disease with modafinil.
@en
P2093
Anette V Nieves
P304
P356
10.1097/00002826-200203000-00010
P50
P577
2002-03-01T00:00:00Z